136 related articles for article (PubMed ID: 36166424)
1. Symptom burden according to dialysis day of the week in three times a week haemodialysis patients.
Hnynn Si PE; Gair R; Barnes T; Dunn L; Lee S; Ariss S; Walters SJ; Wilkie M; Fotheringham J
PLoS One; 2022; 17(9):e0274599. PubMed ID: 36166424
[TBL] [Abstract][Full Text] [Related]
2. Length of Interdialytic Intervals Affects Morbidity and Mortality in Chronic Haemodialysis Patients.
Hakmei JE; Nietert PJ; Fitzgibbon WR; Ullian ME
J Clin Exp Nephrol; 2017; 2(2):. PubMed ID: 31528834
[TBL] [Abstract][Full Text] [Related]
3. The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.
Fotheringham J; Sajjad A; Stel VS; McCullough K; Karaboyas A; Wilkie M; Bieber B; Robinson BM; Massy ZA; Jager KJ
Nephrol Dial Transplant; 2019 Sep; 34(9):1577-1584. PubMed ID: 30820580
[TBL] [Abstract][Full Text] [Related]
4. The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis.
Greenham L; Bennett PN; Dansie K; Viecelli AK; Jesudason S; Mister R; Smyth B; Westall P; Herzog S; Brown C; Handke W; Palmer SC; Caskey FJ; Couchoud C; Simes J; McDonald SP; Morton RL
Trials; 2022 May; 23(1):419. PubMed ID: 35590395
[TBL] [Abstract][Full Text] [Related]
5. Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial.
Kaja Kamal RM; Farrington K; Wellsted D; Sridharan S; Alchi B; Burton J; Davenport A; Vilar E
BMJ Open; 2020 Aug; 10(8):e035919. PubMed ID: 32792431
[TBL] [Abstract][Full Text] [Related]
6. Benefits of a low intensity exercise programme during haemodialysis sessions in elderly patients.
Esteve Simo V; Junqué Jiménez A; Moreno Guzmán F; Carneiro Oliveira J; Fulquet Nicolas M; Pou Potau M; Saurina Sole A; Duarte Gallego V; Tapia Gonzalez I; Ramirez de Arellano M
Nefrologia; 2015; 35(4):385-94. PubMed ID: 26306966
[TBL] [Abstract][Full Text] [Related]
7. Longer interdialytic interval and cause-specific hospitalization in children receiving chronic dialysis.
Springel T; Laskin B; Shults J; Keren R; Furth S
Nephrol Dial Transplant; 2013 Oct; 28(10):2628-36. PubMed ID: 23861468
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial.
Agarwal N; Shah KK; Dansie K; Bennett PN; Greenham L; Brown C; Smyth B; McDonald S; Jesudason S; Viecelli AK; Morton RL;
BMC Nephrol; 2023 Nov; 24(1):345. PubMed ID: 37993776
[TBL] [Abstract][Full Text] [Related]
9. The trajectory of a range of commonly captured symptoms with standard care in people with kidney failure receiving haemodialysis: consideration for clinical trial design.
Hnynn Si PE; Hernández-Alava M; Dunn L; Wilkie M; Fotheringham J
BMC Nephrol; 2023 Nov; 24(1):341. PubMed ID: 37978349
[TBL] [Abstract][Full Text] [Related]
10. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
Yang F; Devlin N; Luo N
Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
[TBL] [Abstract][Full Text] [Related]
11. Do patient-reported measures of symptoms and health status predict mortality in hemodialysis? An assessment of POS-S Renal and EQ-5D.
Sexton DJ; Lowney AC; O'Seaghdha CM; Murphy M; O'Brien T; Casserly LF; McQuillan R; Plant WD; Eustace JA; Kinsella SM; Conlon PJ
Hemodial Int; 2016 Oct; 20(4):618-630. PubMed ID: 27198825
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
[TBL] [Abstract][Full Text] [Related]
13. Patients' perspective of haemodialysis-associated symptoms.
Caplin B; Kumar S; Davenport A
Nephrol Dial Transplant; 2011 Aug; 26(8):2656-63. PubMed ID: 21212166
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine.
Zyoud SH; Daraghmeh DN; Mezyed DO; Khdeir RL; Sawafta MN; Ayaseh NA; Tabeeb GH; Sweileh WM; Awang R; Al-Jabi SW
BMC Nephrol; 2016 Apr; 17(1):44. PubMed ID: 27117687
[TBL] [Abstract][Full Text] [Related]
15. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
16. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
17. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP
J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813
[TBL] [Abstract][Full Text] [Related]
18. Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients.
Khan I; Morris S; Pashayan N; Matata B; Bashir Z; Maguirre J
Health Qual Life Outcomes; 2016 Apr; 14():60. PubMed ID: 27072351
[TBL] [Abstract][Full Text] [Related]
19. Walking ability, anxiety and depression, significantly decrease EuroQol 5-Dimension 5-Level scores in older hemodialysis patients in Japan.
Shimizu U; Aoki H; Sakagami M; Akazawa K
Arch Gerontol Geriatr; 2018; 78():96-100. PubMed ID: 29936330
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of neuromuscular electrostimulation intervention to improve physical function in haemodialysis patients.
Simó VE; Jiménez AJ; Oliveira JC; Guzmán FM; Nicolás MF; Potau MP; Solé AS; Gallego VD; González IT; de Arellano Serna MR
Int Urol Nephrol; 2015 Oct; 47(10):1709-17. PubMed ID: 26253828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
